IMD

Oracle

e731bdd5signed

Is the Novavax COVID-19 vaccine an mRNA, viral vector, or protein subunit vaccine? Answer with 'mRNA', 'viral vector' or 'protein subunit' only.

Answer

protein subunit
vaccineIdentity
Novavax's authorized/approved COVID-19 vaccine, NVX-CoV2373 (marketed as Nuvaxovid), which uses a recombinant spike protein antigen with Matrix-M adjuvant
sources
www.cdc.gov, cdc "types of covid-19 vaccines" (cdc.gov) and fda novavax covid-19 vaccine, adjuvanted fact sheet (fda.gov), both classifying nvx-cov2373 as a protein subunit vaccine, cdc 'novavax covid-19 vaccine' clinician guidance and fda novavax covid-19 vaccine, adjuvanted (nuvaxovid) package insert, both describing the vaccine as a protein subunit vaccine using recombinant spike protein with matrix-m adjuvant, cdc 'understanding how covid-19 vaccines work' and fda nuvaxovid (nvx-cov2373) prescribing information, both describing novavax's vaccine as a protein subunit vaccine, cdc (cdc.gov) and fda (fda.gov) vaccine fact sheets describe nvx-cov2373 / nuvaxovid as a protein subunit vaccine, distinct from the mrna (pfizer, moderna) and viral vector (johnson & johnson) platforms, cdc (https://www.cdc.gov/vaccines/covid-19/index.html) and fda (https://www.fda.gov/vaccines-blood-biologics/novavax-covid-19-vaccine-adjuvanted) both classify nvx-cov2373 as a protein subunit vaccine (recombinant spike protein plus matrix-m adjuvant), distinct from mrna (pfizer/moderna) and viral vector (j&j/astrazeneca) platforms., cdc and fda official descriptions of nvx-cov2373 (novavax) classify it as a protein subunit vaccine, using a recombinant spike protein nanoparticle with matrix-m adjuvant, unlike mrna (pfizer/moderna) or viral vector (j&j/astrazeneca) platforms., cdc and fda vaccine fact sheets / who classification of novavax's nvx-cov2373 (nuvaxovid) as a protein subunit vaccine, as opposed to mrna (pfizer/moderna) or viral vector (j&j/astrazeneca), cdc, 'novavax covid-19 vaccine, adjuvanted' clinical information (https://www.cdc.gov/vaccines/covid-19/info-by-product/novavax/index.html) and fda fact sheet for nvx-cov2373, both describing it as a protein subunit vaccine with matrix-m adjuvant, cdc, covid-19 vaccination: information for health care providers, https://www.cdc.gov/vaccines/hcp/by-disease/covid-19.html, cdc, covid-19 vaccine basics, https://www.cdc.gov/covid/vaccines/how-they-work.html, cdc, covid-19 vaccine basics: https://www.cdc.gov/covid/vaccines/how-they-work.html, cdc, covid-19 vaccine basics: https://www.cdc.gov/covid/vaccines/how-they-work.html (section: protein subunit vaccines (novavax)), cdc, covid-19 vaccine safety: https://www.cdc.gov/vaccine-safety/vaccines/covid-19.html, cdc, overview of covid-19 vaccines and vaccination (https://www.cdc.gov/covid/hcp/vaccine-considerations/overview.html), cdc, overview of covid-19 vaccines and vaccination, https://www.cdc.gov/covid/hcp/vaccine-considerations/overview.html (novavax listed under protein subunit vaccine), fda (fda.gov) novavax covid-19 vaccine, adjuvanted fact sheet and cdc (cdc.gov) vaccine basics page both describe novavax's covid-19 vaccine as a protein subunit vaccine (recombinant spike protein nanoparticle with matrix-m adjuvant), distinct from the mrna (pfizer/moderna) and viral vector (johnson & johnson) platforms., fda (fda.gov) novavax/nuvaxovid emergency use authorization and prescribing information; cdc (cdc.gov) covid-19 vaccine types page, both describing nvx-cov2373 as a protein subunit vaccine (adjuvanted recombinant spike protein nanoparticle), fda - nuvaxovid (novavax covid-19 vaccine, adjuvanted) prescribing information / bla approval materials, describing nvx-cov2373 as a protein subunit vaccine, fda and cdc: novavax covid-19 vaccine, adjuvanted (nuvaxovid) is a protein subunit vaccine, using a recombinant spike protein with matrix-m adjuvant, unlike mrna vaccines (pfizer/moderna) or viral vector vaccines (johnson & johnson/astrazeneca)., fda novavax covid-19 vaccine, adjuvanted authorization materials / package insert describing nuvaxovid as a protein subunit (recombinant nanoparticle) vaccine, fda press release on novavax covid-19 vaccine, adjuvanted (nuvaxovid) eua/approval, and cdc vaccine information describing nvx-cov2373 as a protein subunit vaccine, fda, novavax covid-19 vaccine, adjuvanted (2024-2025 formula) decision memorandum, https://www.fda.gov/media/181494/download, novavax nuvaxovid (nvx-cov2373) is an adjuvanted protein subunit vaccine using recombinant spike protein nanoparticle technology, per novavax's official product information and cdc/who vaccine classification references., novavax, inc. official corporate description of nvx-cov2373 (https://www.novavax.com) and u.s. fda fact sheet for nvx-cov2373, both of which classify it as a protein subunit vaccine using recombinant nanoparticle technology with matrix-m adjuvant., u.s. cdc and fda vaccine fact sheets / novavax official product information describing nvx-cov2373 (nuvaxovid) as a protein subunit vaccine using recombinant nanoparticle technology with matrix-m adjuvant, u.s. cdc and fda: novavax covid-19 vaccine is a protein subunit vaccine (adjuvanted recombinant spike protein nanoparticle), unlike the mrna (pfizer/moderna) or viral vector (j&j) vaccines., u.s. cdc, 'novavax covid-19 vaccine, adjuvanted' clinical overview: describes nvx-cov2373 as a protein subunit vaccine (recombinant spike protein plus matrix-m adjuvant), distinct from the mrna (pfizer/moderna) and viral vector (j&j/astrazeneca) platforms., u.s. fda, novavax covid-19 vaccine, adjuvanted (nvx-cov2373) fact sheet / approval materials, which describe it as a protein subunit vaccine, u.s. fda, nuvaxovid (novavax covid-19 vaccine, adjuvanted) prescribing information and approval materials, describing it as a protein subunit vaccine; corroborated by cdc covid-19 vaccine type overview classifying novavax's vaccine as protein subunit., us fda vaccine fact sheet and cdc description of novavax covid-19 vaccine, adjuvanted (nvx-cov2373): a protein subunit vaccine, unlike the mrna vaccines (pfizer/moderna) or viral vector vaccines (janssen/astrazeneca), www.cdc.gov, www.fda.gov, www.who.int

Work

  1. pinnedblocks 26,084,043 to 26,084,343 to · on Ethereum mainnet
  2. answered148 of 148 agreed140 needed
    #339protein subunitfrom www.cdc.gov
    #835protein subunitfrom www.cdc.gov
    #1285protein subunitfrom www.cdc.gov
    #294protein subunitfrom www.fda.gov
    #355protein subunitCDC 'Understanding How COVID-19 Vaccines Work' and FDA Nuvaxovid (NVX-CoV2373) prescribing information, both describing Novavax's vaccine as a protein subunit vaccine
    143 more
  3. signed
    by the attester 0x5598…2982usable until

    Checking the signature in this browser.

    typed data
    the exact bytes a consumer verifies, as JSON
    attester
    0x5598aa9146215bc13eb26f2c692ad1461fd32982
    signature
    0xd99234949e66a22dea618dc94c6e30b65b1b092d040d8e3b37eec8fec133fedc2cba54780096e333e4a018089375d02d4daa6d00ac6d68fcf20d80c45c6dcfcf1c
    question hash
    0x3b60d3a368594a962c44f145569f782a9a8742d4a12a6efe9c6edcc6384b7606
    answer type
    bytes32
    consumer
    none named; signed for the zero address
  4. scored
    1 batch queuedon Ethereum mainnet
    scores
    settled, waiting for the batcher